MEGAN GOODMAN: Open Payments
NPI 1386048239 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$275 in 6 payments from 6 companies in 2025. Trend: 2023 $27 · 2024 $276 · 2025 $275
Food & beverage: $275
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 1 | $149 |
| Krystal Biotech Inc | 1 | $33 |
| Chiesi USA, Inc. | 1 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| LNHC, Inc | 1 | $20 |
Products named: DAXI, VYJUVEK, FILSUVEZ, VIJOICE, ICLUSIG, ZELSUVMI.
Industry payments across AZ — which companies pay providers there.
